Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 81, Issue 2, Pages 206-213
Publisher
BMJ
Online
2022-01-13
DOI
10.1136/annrheumdis-2021-220822
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial
- (2021) René Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
- (2021) Bernard Combe et al. ANNALS OF THE RHEUMATIC DISEASES
- A systematic literature review of herpes zoster incidence worldwide
- (2021) Désirée van Oorschot et al. Human Vaccines & Immunotherapeutics
- The safety of JAK-1 inhibitors
- (2021) Benjamin Clarke et al. RHEUMATOLOGY
- POS0092 HERPES ZOSTER IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM
- (2021) K. Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
- (2021) Kunihiro Yamaoka et al. DRUG SAFETY
- Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
- (2020) Kevin L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study
- (2020) Hideto Kameda et al. RHEUMATOLOGY
- Infections in baricitinib clinical trials for patients with active rheumatoid arthritis
- (2020) Kevin L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of recurrent herpes zoster in a population-based cohort study of older adults
- (2020) Jiahui Qian et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A review of upadacitinib in rheumatoid arthritis
- (2020) Yoshiya Tanaka Modern Rheumatology
- Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐naïve Patients with Moderately to Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Randomized, Double‐blind, Active‐comparator, Multi‐center, Multi‐country Trial
- (2020) Ronald van Vollenhoven et al. Arthritis & Rheumatology
- Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
- (2020) Andrea Rubbert-Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials
- (2019) Masayoshi Harigai et al. Modern Rheumatology
- Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
- (2019) Josef S Smolen et al. LANCET
- Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3)
- (2019) Yoshiya Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy
- (2019) Mark C. Genovese et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Upadacitinib versus Placebo or Adalimumab in Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase 3, Double‐Blind, Randomized Controlled Trial
- (2019) Roy Fleischmann et al. Arthritis & Rheumatology
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2019) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial
- (2018) Mark C Genovese et al. LANCET
- Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Gerd R Burmester et al. LANCET
- Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
- (2018) Josef S. Smolen et al. JOURNAL OF RHEUMATOLOGY
- Clinical Features of Varicella-Zoster Virus Infection
- (2018) Peter Kennedy et al. Viruses-Basel
- Herpes Zoster in Tofacitinib: Risk is Further Increased with Glucocorticoids but not Methotrexate
- (2018) Jeffrey R Curtis et al. ARTHRITIS CARE & RESEARCH
- Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials
- (2017) Yoshiya Tanaka et al. Modern Rheumatology
- The emerging safety profile of JAK inhibitors in rheumatic disease
- (2017) Kevin L. Winthrop Nature Reviews Rheumatology
- The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial
- (2017) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy
- (2017) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Quantification of risk factors for postherpetic neuralgia in herpes zoster patients
- (2016) Harriet J. Forbes et al. NEUROLOGY
- Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination
- (2016) Huifeng Yun et al. Arthritis & Rheumatology
- Systematic review of incidence and complications of herpes zoster: towards a global perspective
- (2014) K. Kawai et al. BMJ Open
- Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
- (2014) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Herpes Zoster
- (2013) Jeffrey I. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) D. Aletaha et al. ANNALS OF THE RHEUMATIC DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now